Genvisc 850: Affordable HA Knee Injection (2026)

Q: How much does Genvisc 850 cost with Medicare?

Most Medicare Part B patients pay $75 to $200 out of pocket for a full Genvisc 850 treatment series after their annual deductible is met. Medicare covers 80 percent of the approved amount, and you pay the remaining 20 percent. If you have a Medicare Supplement (Medigap) plan, your out-of-pocket cost may be even lower.

Q: How many injections do I need?

The standard course is 3 to 5 weekly injections, depending on your doctor's recommendation and your response to treatment. Each injection is given one week apart in your doctor's office.

Quick Answer

Genvisc 850 is a sodium hyaluronate injection made by OrthogenRx for knee osteoarthritis. It uses the same active ingredient as Hyalgan but typically costs less, making it one of the most affordable hyaluronic acid (HA) options on the market. A full treatment course of 3 to 5 injections usually runs $400 to $700 without insurance, and Medicare covers it under billing code J7320. If cost is a factor in your treatment decision, Genvisc 850 deserves a close look.

What Is Genvisc 850?

Genvisc 850 is a viscosupplementation injection that adds hyaluronic acid back into your knee joint. Hyaluronic acid is a substance your body produces naturally. It acts as a lubricant and shock absorber in healthy joints. When osteoarthritis breaks down cartilage, the concentration and quality of hyaluronic acid in your joint fluid drops. Genvisc 850 supplements what your knee has lost.

The product is manufactured by OrthogenRx, a company that specializes in orthopedic injectables. The active ingredient is sodium hyaluronate, the same molecule found in Hyalgan, one of the oldest and most studied HA brands on the market.

Key Facts at a Glance

Feature	Details
Manufacturer	OrthogenRx
Active ingredient	Sodium hyaluronate
Molecular weight	850 kDa (medium)
Source	Biofermented (non-avian)
Injection schedule	3 to 5 weekly injections
FDA status	FDA-cleared for knee OA
Medicare billing code	J7320 (shared with Hyalgan)
Typical cost	$400-$700 per treatment course

Because Genvisc 850 shares the J7320 billing code with Hyalgan, it processes through insurance the same way. This is important for Medicare patients because it means coverage and reimbursement follow the same rules.

How Genvisc 850 Compares to Other Brands

One of the most common questions patients ask is how Genvisc 850 stacks up against other gel injection brands. Here is an honest comparison.

Genvisc 850 vs. Hyalgan

These two products are very similar. Both contain sodium hyaluronate and share the same Medicare billing code (J7320).

Factor	Genvisc 850	Hyalgan
Active ingredient	Sodium hyaluronate	Sodium hyaluronate
Injection series	3-5 weekly	3-5 weekly
Source	Biofermented	Avian-derived
Bird allergy safe	Yes	No
Typical cost	$400-$700	$500-$900
Medicare code	J7320	J7320
Years of clinical data	Fewer studies	25+ years of data

Key takeaway: Genvisc 850 is functionally similar to Hyalgan but often costs less and is safe for patients with bird or egg allergies because it is biofermented rather than avian-derived.

Genvisc 850 vs. Synvisc-One

Factor	Genvisc 850	Synvisc-One
Injections	3-5 weekly	1 single injection
Technology	Non-cross-linked	Cross-linked gel
Relief duration	3-6 months	Up to 6 months
Typical cost	$400-$700	$1,000-$1,500
Medicare code	J7320	J7325

Synvisc-One is more convenient because it requires only one injection, but it costs significantly more. Some insurers require patients to try a lower-cost product like Genvisc 850 before approving Synvisc-One. This is called step therapy.

Genvisc 850 vs. Euflexxa

Factor	Genvisc 850	Euflexxa
Injections	3-5 weekly	3 weekly
Source	Biofermented	Biofermented
Typical cost	$400-$700	$700-$1,100
Medicare code	J7320	J7323

Both products are biofermented and safe for patients with bird allergies. Euflexxa typically costs more per treatment course.

The 3 to 5 Injection Schedule

Genvisc 850 is administered as a series of weekly injections. Your doctor will determine whether you need 3 or 5 injections based on your knee condition and how you respond to treatment.

What Happens at Each Visit

Check-in: Your doctor examines the knee and checks for excess fluid
Preparation: The injection site is cleaned and may be numbed with a local anesthetic
Injection: About 2 mL of Genvisc 850 is injected directly into the knee joint space
After care: You rest briefly and then can usually drive yourself home

Each appointment takes about 15 to 30 minutes.

Recovery Between Injections

First 48 hours: Avoid jogging, heavy lifting, or prolonged standing. Gentle walking is fine.

Ice as needed: Apply ice for 15 to 20 minutes if you have swelling or soreness at the injection site.

Full relief timeline: Most patients notice improvement 2 to 4 weeks after completing the full injection series.

Medicare Coverage for Genvisc 850

This is where Genvisc 850 really stands out for patients on Medicare.

How Medicare Covers It

Medicare Part B covers Genvisc 850 for knee osteoarthritis when medical necessity criteria are met.

To qualify, you generally need:

A documented diagnosis of knee osteoarthritis
Evidence that conservative treatments have been tried first (physical therapy, over-the-counter pain relievers, exercise)
A doctor who determines the injection is medically necessary

The J7320 Billing Code

Genvisc 850 is billed under HCPCS code J7320, the same code used for Hyalgan and other sodium hyaluronate products. This matters because:

Medicare reimbursement rates are the same as for Hyalgan
Claims processors are familiar with this code
There are fewer insurance denials compared to newer or less common codes

What You Will Pay

Coverage scenario	Estimated out-of-pocket cost
Medicare Part B	$75-$200 for the full series (after deductible and 20% coinsurance)
Medicare Advantage	Varies by plan; check with your insurer
Private insurance	$100-$300 depending on plan and deductible
No insurance	$400-$700 for the full series

Medicare patients typically pay around $75 to $200 for a complete Genvisc 850 treatment course after their Part B deductible is met. That makes it one of the lowest out-of-pocket treatments available for knee osteoarthritis.

Pros and Cons of Genvisc 850

Advantages

Most affordable HA option: At $400-$700 per treatment course without insurance, Genvisc 850 is typically the least expensive hyaluronic acid injection available.

Medicare covered: Covered under Part B with the well-established J7320 code, resulting in fewer coverage headaches.

Bird allergy safe: Biofermented production means no risk for patients with bird, egg, or feather allergies.

Same active ingredient as Hyalgan: Sodium hyaluronate with decades of safety data behind it.

Step therapy advantage: Insurers often approve Genvisc 850 as a first-line treatment, making it easier to get started without prior authorization battles.

Considerations

Requires 3-5 weekly visits: Unlike single-injection options like Synvisc-One or Gel-One, you need to return to the office weekly for several weeks.

Less brand recognition: Your doctor may not mention Genvisc 850 by name. If cost matters to you, it is worth asking about it specifically.

Fewer published studies: While it uses the same active ingredient as Hyalgan, Genvisc 850 itself has fewer brand-specific clinical trials than older products.

Relief duration varies: Most patients get 3 to 6 months of relief, though individual results differ.

Who Is Genvisc 850 Best For?

Genvisc 850 may be a good fit if you:

Are on Medicare and want the most affordable covered option
Have bird or egg allergies and need a non-avian product
Prefer gradual dosing with smaller weekly injections rather than one large injection
Are starting HA treatment for the first time and want to try the least expensive option first
Need to satisfy step therapy requirements before your insurer will approve a more expensive brand

It may not be the best choice if you:

Cannot commit to 3 to 5 weekly office visits
Want the longest possible duration of relief (cross-linked gels may last longer)
Have had previous HA injections and did not respond well to multi-dose protocols

Get Our Free Gel Injection Insurance Guide

A plain-language guide to getting your gel injections covered by Medicare or private insurance.

Join 10,000+ readers. No spam.

Frequently Asked Questions

Is Genvisc 850 the same as Hyalgan?

Not exactly, but they are very similar. Both contain sodium hyaluronate as the active ingredient and share the J7320 Medicare billing code. The main differences are the manufacturer (OrthogenRx vs. Fidia Farmaceutici) and the production method. Genvisc 850 is biofermented while Hyalgan is avian-derived. In terms of how they work in your knee, they are functionally comparable.

How much does Genvisc 850 cost with Medicare?

Most Medicare Part B patients pay $75 to $200 out of pocket for a full Genvisc 850 treatment series after their annual deductible is met. Medicare covers 80 percent of the approved amount, and you pay the remaining 20 percent. If you have a Medicare Supplement (Medigap) plan, your out-of-pocket cost may be even lower.

Is Genvisc 850 FDA approved?

Yes. Genvisc 850 is FDA-cleared for the treatment of pain associated with knee osteoarthritis in patients who have not responded adequately to conservative treatments and simple pain relievers.

How many injections do I need?

The standard course is 3 to 5 weekly injections, depending on your doctor’s recommendation and your response to treatment. Each injection is given one week apart in your doctor’s office.

Can I get Genvisc 850 if I have bird allergies?

Yes. This is one of Genvisc 850’s key advantages. It is produced through biofermentation, not derived from rooster combs like Hyalgan or Supartz. Patients with allergies to birds, eggs, or feathers can safely receive Genvisc 850. For a deeper look at allergy considerations with gel injections, see our guide to bird allergies and gel injections.

The Bottom Line

Genvisc 850 is not the flashiest hyaluronic acid brand. You will not see television commercials for it, and your doctor may not mention it by name. But for patients who care about cost, especially those on Medicare, it is hard to beat.

It uses the same proven active ingredient as Hyalgan, processes through insurance with the same familiar billing code, costs less than most competing brands, and is safe for patients with bird allergies. The trade-off is a multi-injection schedule and less brand-specific research.

If you are considering gel injections for knee osteoarthritis and want to keep costs low, ask your doctor whether Genvisc 850 is appropriate for your situation. You can also learn more in our complete guide to hyaluronic acid injections or explore our brand comparison guide.

Disclaimer: This article provides educational information only and does not replace consultation with a qualified healthcare provider. Treatment decisions should be made with your doctor based on your individual medical history and needs.

Last reviewed: March 2026